https://catalystwire.co/situations/chrysalis-investments-limited-shareholder-consultation-and-structural-review-v2414CatalystWireen2026-10-27T22:02:58+01:00Chrysalis Investments (CHRY) first compulsory redemptionhttps://catalystwire.co/situations/tullow-oil-profit-upgrade-v5449CatalystWireen2026-10-27T22:02:46+01:00Tullow Oil (TLW) profit upgrade: half year results and guidancehttps://catalystwire.co/situations/vistry-group-return-to-net-cash-v3194CatalystWireen2026-10-27T22:02:39+01:00Vistry Group (VTY): net cash target cut to broadly neutralhttps://catalystwire.co/situations/puretech-health-deupirfenidone-ipf-phase-3-v2712CatalystWireen2026-10-27T22:02:29+01:00PureTech Health (PRTC): Celea deupirfenidone IPF Phase 3 trialhttps://catalystwire.co/situations/auction-technology-group-fitzwalter-capital-limited-campaign-v472CatalystWireen2026-10-27T22:02:25+01:00Auction Technology Group (ATG): FitzWalter activist requisitionhttps://catalystwire.co/situations/roadside-real-estate-cambridge-sleep-sciences-exit-v2617CatalystWireen2026-10-27T22:02:18+01:00Roadside Real Estate (ROAD): Cambridge Sleep Sciences disposalhttps://catalystwire.co/situations/system1-group-offer-for-the-company-v4181CatalystWireen2026-10-27T22:02:12+01:00System1 Group (SYS1) takeover offer from Brave Bison lapses